8 completed, 2 withdrawn, 1 unknown. 11 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 11 | Completed 8, Withdrawn 2, Unknown 1 |
Follow Exercise-Induced Allergies: new trials by email Literature Review of Exercise-Induced Allergies trials Research Report on Exercise-Induced Allergies
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Investigate the Effects of PT027 (Budesonide/Albuterol Sulfate) Metered-dose Inhaler Compared With Placebo on Exercise-Induced Bronchoconstriction in Adult Patients With Asthma Budesonide/albuterol metered-dose inhaler 160/180 μg, Placebo metered-dose inhaler - Asthma, Exercise-Induced | Phase 3 | Completed | AstraZeneca | 64 | 2023-12-22 | 2025-08-27 |
| A Study to Assess the Efficacy of Budesonide/Albuterol Metered-dose Inhaler (BDA MDI/PT027) on Exercise-induced Bronchoconstriction in Adults and Adolescents With Asthma Budesonide/albuterol sulfate metered-dose inhaler 160/180 μg, Placebo metered-dose inhaler - Exercise Induced Bronchospasm | Phase 3 | Completed | Bond Avillion 2 Development LP | 60 | 2020-01-15 | 2022-01-13 |
| The Effect of Benralizumab on Exercise-induced Bronchoconstriction Benralizumab - Asthma, Exercise-Induced | Phase 3 | Unknown | Louis-Philippe Boulet | 40 | 2017-12-01 | 2017-10-31 |
| A Study of a New Asthma Medicine in Asthmatics Whose Asthma Worsens With Exercise Fluticasone Furoate/Vilanterol Inhalation Powder, Fluticasone Propionate Inhalation Powder - Asthma | Phase 3 | Withdrawn | GlaxoSmithKline | 2012-01-01 | 2014-06-23 | |
| Bronchoprotective Effect of Arformoterol in Children With Exercise-Induced Bronchospasm (EIB) arformoterol, formoterol, placebo - Exercise-induced Bronchospasm | Phase 3 | Withdrawn | University of New Mexico | 2008-04-01 | 2015-12-11 | |
| Two Investigational Drugs in the Prevention of Airway Constriction Brought on by Exercise in Participants With Asthma (0476-911) Montelukast sodium, Salmeterol xinafoate, Fluticasone propionate - Exercise Induced Asthma | Phase 3 | Completed | Organon and Co | 154 | 2005-12-01 | 2024-05-10 |
| Montelukast Compared With Placebo and Salmeterol in Exercise-Induced Bronchoconstriction (0476-316) Comparator: Montelukast, Comparator: Salmeterol, Comparator: Placebo (montelukast) - Asthma, Exercise-Induced | Phase 3 | Completed | Organon and Co | 47 | 2005-12-01 | 2022-02-02 |
| Efficacy Study of Single-Dose Levalbuterol Tartrate HFA MDI Vs Placebo in Subjects 18 Years and Older With EIB Levalbuterol tartrate HFA MDI, Placebo - Exercise-induced Bronchospasm | Phase 3 | Completed | Sumitomo Pharma America, Inc. | 15 | 2005-12-01 | 2012-02-22 |
| Comparison of Two Bronchodilator Inhalers in Adolescents and Adults With Exercise-Induced Asthma albuterol aerosol by HFA MDI, albuterol aerosol by HFA BOI, placebo aerosol by HFA - Exercise-induced Bronchospasm | Phase 3 | Completed | Teva Branded Pharmaceutical Products R&D, Inc. | 24 | 2004-06-30 | 2021-11-24 |
| Montelukast in Exercise-Induced Bronchospasm - 2004 (0476-275) Comparator: Montelukast, Comparator: Placebo - Asthma, Exercise-Induced | Phase 3 | Completed | Organon and Co | 62 | 2004-05-01 | 2022-02-02 |
| Montelukast in Exercise-Induced Bronchospasm - 2003 (0476-270) Comparator: Montelukast, Comparator: Placebo - Asthma, Exercise-Induced | Phase 3 | Completed | Organon and Co | 51 | 2003-06-01 | 2022-02-02 |
Asthma, Exercise-Induced (11) · Asthma (3) · Bronchial Spasm (1) · Motor Activity (1)
Bronchial Diseases (11) · Hypersensitivity (11) · Hypersensitivity, Immediate (11) · Immune System Diseases (11) · Respiratory Hypersensitivity (11) · Respiratory Tract Diseases (11) · Asthma (8) · Lung Diseases (3) · Lung Diseases, Obstructive (3) · Behavior (1)
Budesonide (2) · Salmeterol Xinafoate (2) · montelukast (2) · Fluticasone (1) · Formoterol Fumarate (1) · benralizumab (1) · fluticasone furoate (1)
Organon and Co (4) · AstraZeneca (1) · Bond Avillion 2 Development LP (1) · GlaxoSmithKline (1) · Louis-Philippe Boulet (1) · Sumitomo Pharma America, Inc. (1) · Teva Branded Pharmaceutical Products R&D, Inc. (1) · University of New Mexico (1)
United States (4) · Russia (1)
David S Pearlman, MD (1) · Frank Albers, MD, PhD (1) · Hengameh Raissy, Pharm.D. (1) · Louis-Philippe Boulet, MD (1)